India releases revised operational guidelines of non-alcoholic fatty liver disease
India has taken the lead in recognising NAFLD as a major non-communicable disease
India has taken the lead in recognising NAFLD as a major non-communicable disease
The study highlighted substantial improvements in key clinical parameters among RA patients who underwent AWS intervention
New Chair brings extensive experience in global pharmaceutical and biotechnology leadership, healthcare innovation, and strategic drug development
He advocated for a "PPP + PPP" collaboration, urging the public and private sectors within India to partner with their counterparts in other countries
Observes no adverse impact of non-nutritive sweetener (NNS) - sucralose on glycemic markers
Nelarabine is a nucleoside metabolic inhibitor indicated for the treatment of patients with T-cell acute lymphoblastic leukemia
Partners with Yifan Pharmaceutical to launch Synovian injection for osteoarthritis in China
GL0034 administered once-weekly confirmed clinically meaningful weight loss and improved glucometabolic parameters over a 4-week treatment period in individuals with obesity
Subscribe To Our Newsletter & Stay Updated